Heart Valve Devices Market to Increase at a 11.9% CAGR from 2022 to 2031, Reaching US$ 26.3 Billion | Exclusive Report by Transparency Market Research

The global 𝐡𝐞𝐚𝐫𝐭 𝐯𝐚𝐥𝐯𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 witnessed significant growth in 2021, reaching a valuation of US$ 8.7 billion. Projections indicate a robust compound annual growth rate (CAGR) of 11.9% from 2022 to 2031, with the market anticipated to surpass US$ 26.3 billion by the end of 2031.

Analysts attribute this growth to advancements in structural heart devices and procedures, particularly in aortic valve replacement valves, left arterial closure devices, and tissue or biological valves. However, the increasing costs associated with minimally invasive procedures pose a challenge, deterring some patients from opting for surgery. To address these concerns, manufacturers are urged to prioritize factors such as efficacy, reproducibility, versatility, and technical complexity in product development.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=486&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

Additionally, there is a growing focus on creating heart valves from synthetic materials to enhance durability and mechanical function, thereby reducing the need for anticoagulant and antithrombotic therapy. These strategies are expected to drive innovation and sustainability in the global heart valve devices market.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬-

Abbott, Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, and Medtronic, Inc.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧-

𝐓𝐲𝐩𝐞

Mechanical Heart Valve
Biological Heart Valve
Transcatheter Aortic Valve

𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥

Hospitals
Ambulatory Surgical Centers
Others (Cardiac Centers, Research Centers, etc.)

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Market Dynamics Analysis
Competitive Landscape Assessment
Regulatory Framework Analysis
Investment Feasibility Study
Emerging Market Trends Evaluation

𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐎𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭𝐬: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=486&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐆𝐥𝐨𝐛𝐚𝐥 𝐇𝐞𝐚𝐫𝐭 𝐕𝐚𝐥𝐯𝐞 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

𝐈𝐧 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟏, Abbott announced the U.S. Food and Drug Administration (FDA) approval for Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. These next-generation devices are built off Abbott's Epic surgical valve platform.

𝐈𝐧 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟎, Boston Scientific launched a new aortic valve system. This transcatheter aortic valve implantation (TAVI) is a new heart valve technology designed with many features to improve the older clinical performance of the Acurate neo platform.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬-

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future outlook for the heart valve devices market remains promising, driven by ongoing technological innovations, expanding indications for heart valve procedures, and increasing investments in healthcare infrastructure. Moreover, growing demand for minimally invasive treatment options and rising healthcare awareness among the population are expected to further propel market growth.

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=486<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐇𝐕𝐀𝐂 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/06/09/2685825/0/en/Global-HVAC-Equipment-Market-to-Increase-at-a-5-8-CAGR-from-2022-to-2031-Reaching-US-199-2-Billion-Exclusive-Report-by-Transparency-Market-Research.html

𝐅𝐥𝐨𝐨𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/06/09/2685768/0/en/Flooring-Market-is-Estimated-to-Reach-Revenue-of-US-614-0-Billion-by-2031-The-Ceramic-Tile-Segment-Held-a-43-2-Value-Share-of-the-Market-in-2021.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.